The Chemours Company $CC Holdings Raised by Teacher Retirement System of Texas

Teacher Retirement System of Texas boosted its stake in The Chemours Company (NYSE:CC) by 15.1% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 67,911 shares of the specialty chemicals company’s stock after buying an additional 8,917 shares during the period. Teacher Retirement System of Texas’ holdings in Chemours were worth $778,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Millennium Management LLC boosted its stake in Chemours by 60.4% during the 1st quarter. Millennium Management LLC now owns 4,022,782 shares of the specialty chemicals company’s stock valued at $54,428,000 after purchasing an additional 1,515,520 shares in the last quarter. Principal Financial Group Inc. boosted its stake in Chemours by 116.3% during the first quarter. Principal Financial Group Inc. now owns 742,119 shares of the specialty chemicals company’s stock valued at $10,041,000 after buying an additional 399,097 shares in the last quarter. Charles Schwab Investment Management Inc. grew its holdings in Chemours by 10.5% during the first quarter. Charles Schwab Investment Management Inc. now owns 1,438,732 shares of the specialty chemicals company’s stock worth $19,466,000 after acquiring an additional 136,460 shares during the period. XTX Topco Ltd acquired a new position in Chemours during the first quarter worth about $285,000. Finally, Russell Investments Group Ltd. raised its position in Chemours by 610.5% in the first quarter. Russell Investments Group Ltd. now owns 66,180 shares of the specialty chemicals company’s stock worth $896,000 after acquiring an additional 56,866 shares in the last quarter. Institutional investors and hedge funds own 76.26% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have recently issued reports on CC. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Chemours in a research note on Wednesday, October 8th. Zacks Research downgraded Chemours from a “hold” rating to a “strong sell” rating in a report on Friday, October 17th. UBS Group upped their price objective on shares of Chemours from $17.00 to $21.00 and gave the company a “buy” rating in a research note on Monday, October 6th. Mizuho dropped their target price on shares of Chemours from $19.00 to $18.00 and set an “outperform” rating on the stock in a research report on Thursday, October 16th. Finally, Truist Financial boosted their price target on shares of Chemours from $18.00 to $21.00 and gave the company a “buy” rating in a report on Tuesday, September 16th. Five analysts have rated the stock with a Buy rating, three have issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $18.50.

Chemours Trading Up 6.9%

Shares of NYSE:CC opened at $12.56 on Friday. The company has a market capitalization of $1.88 billion, a PE ratio of -5.66 and a beta of 1.64. The Chemours Company has a 12-month low of $9.13 and a 12-month high of $22.38. The business has a 50 day moving average of $14.88 and a two-hundred day moving average of $13.22. The company has a current ratio of 1.68, a quick ratio of 0.83 and a debt-to-equity ratio of 17.16.

Chemours (NYSE:CC) last posted its earnings results on Thursday, November 6th. The specialty chemicals company reported $0.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.24 by ($0.04). Chemours had a negative net margin of 5.70% and a positive return on equity of 32.02%. The firm had revenue of $1.50 billion during the quarter, compared to analyst estimates of $1.50 billion. During the same quarter in the prior year, the firm earned $0.40 earnings per share. The business’s revenue for the quarter was down .9% on a year-over-year basis. Chemours has set its Q4 2025 guidance at EPS. FY 2025 guidance at EPS. As a group, analysts forecast that The Chemours Company will post 2.03 EPS for the current year.

Chemours Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, December 15th. Stockholders of record on Friday, November 14th will be given a dividend of $0.0875 per share. The ex-dividend date is Friday, November 14th. This represents a $0.35 dividend on an annualized basis and a dividend yield of 2.8%. Chemours’s dividend payout ratio (DPR) is -12.50%.

Chemours Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.